Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
BACKGROUND
Lymphadenectomy is debated in early stages endometrial cancer. Moreover, a new FIGO classification of endometrial cancer, merging stages IA and IB has been recently published. Therefore, the aims of the present study was to evaluate the relevance of the sentinel node (SN) procedure in women with endometrial cancer and to discuss whether the use of the 2009 FIGO classification could modify the indications for SN procedure.


METHODS
Eighty-five patients with endometrial cancer underwent the SN procedure followed by pelvic lymphadenectomy. SNs were detected with a dual or single labelling method in 74 and 11 cases, respectively. All SNs were analysed by both H&E staining and immunohistochemistry. Presumed stage before surgery was assessed for all patients based on MR imaging features using the 1988 FIGO classification and the 2009 FIGO classification.


RESULTS
An SN was detected in 88.2% of cases (75/85 women). Among the fourteen patients with lymph node metastases one-half were detected by serial sectioning and immunohistochemical analysis. There were no false negative case. Using the 1988 FIGO classification and the 2009 FIGO classification, the correlation between preoperative MRI staging and final histology was moderate with Kappa = 0.24 and Kappa = 0.45, respectively. None of the patients with grade 1 endometrioid carcinoma on biopsy and IA 2009 FIGO stage on MR imaging exhibited positive SN. In patients with grade 2-3 endometrioid carcinoma and stage IA on MR imaging, the rate of positive SN reached 16.6% with an incidence of micrometastases of 50%.


CONCLUSIONS
The present study suggests that sentinel node biopsy is an adequate technique to evaluate lymph node status. The use of the 2009 FIGO classification increases the accuracy of MR imaging to stage patients with early stages of endometrial cancer and contributes to clarify the indication of SN biopsy according to tumour grade and histological type.
Ballester
Marcos
M
Service de Gynécologie-Obstétrique, hôpital Tenon, AP-HP, CancerEst, Université Pierre et Marie Curie, Paris VI, France. emile.darai@tnn.aphp.fr.
Koskas
Martin
M
Coutant
Charles
C
Chéreau
Elisabeth
E
Seror
Jeremy
J
Rouzier
Roman
R
Daraï
Emile
E
D018262:Adenocarcinoma, Clear Cell / Q000145:classification / Q000473:pathology* / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018196:Carcinoma, Adenosquamous / Q000145:classification / Q000473:pathology* / Q000601:surgery; D002291:Carcinoma, Papillary / Q000145:classification / Q000473:pathology* / Q000601:surgery; D018284:Cystadenocarcinoma, Serous / Q000145:classification / Q000473:pathology* / Q000601:surgery; D016889:Endometrial Neoplasms / Q000145:classification / Q000473:pathology* / Q000601:surgery; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D021701:Sentinel Lymph Node Biopsy; D015996:Survival Rate
Gynecol Oncol. 2009 Aug;114(2):284-7
19447478
Cancer. 1987 Oct 15;60(8 Suppl):2035-41
3652025
Int J Gynaecol Obstet. 2009 May;105(2):109
19345353
Gynecol Oncol. 2005 Jun;97(3):727-32
15943983
Gynecol Oncol. 2001 Feb;80(2):139-44
11161851
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):69-74
19195765
J Surg Oncol. 2009 Mar 15;99(4):232-41
19072933
Int J Gynaecol Obstet. 2009 May;105(2):110-1
19285672
Nucl Med Commun. 2003 Sep;24(9):971-5
12960596
Gynecol Oncol. 2007 Jan;104(1):100-3
16963111
Med Sci Monit. 2004 Oct;10(10):CR587-91
15448599
Gynecol Oncol. 2009 May;113(2):163-9
19232699
Gynecol Oncol. 2005 Nov;99(2):309-12
16005945
Gynecol Oncol. 2007 May;105(2):457-61
17313975
J Clin Oncol. 2002 Sep 1;20(17):3628-36
12202663
Lancet. 2009 Jan 10;373(9658):125-36
19070889
Gynecol Oncol. 2004 Feb;92(2):669-74
14766264
Gynecol Oncol. 2008 Oct;111(1):13-7
18684499
Am J Obstet Gynecol. 2000 Jun;182(6):1506-19
10871473
Gynecol Oncol. 2007 Jul;106(1):89-93
17442383
Radiology. 2000 Aug;216(2):444-9
10924568
Cancer. 1993 Feb 15;71(4 Suppl):1460-3
8431880
Gynecol Oncol. 2009 Nov;115(2):236-8
19666190
J Surg Oncol. 2008 Feb 1;97(2):141-5
18050286
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16
19033573
Surg Oncol. 2008 Sep;17(3):227-35
18504122
Eur J Gynaecol Oncol. 2004;25(3):339-42
15171314
Ann Oncol. 2007 Nov;18(11):1799-803
17709801
Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1113-7
17386045
Surg Oncol. 2008 Sep;17(3):237-45
18499443
Gynecol Oncol. 2007 Jun;105(3):683-6
17442382
Ann Surg Oncol. 2008 May;15(5):1523-9
18322758
Gynecol Oncol. 2001 Apr;81(1):100-4
11277658